• A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

Bendamustine

Bendamustine | CAS NO: 3543-75-7., Bendamustine is primarily used in the treatment of certain types of cancer. Chronic Lymphocytic Leukemia (CLL): Bendamustine is often used for patients with CLL, particularly in cases where other treatments have failed. Non-Hodgkin Lymphoma (NHL): It is effective for certain types of NHL, including follicular lymphoma. Multiple Myeloma: Bendamustine may be used in combination with other drugs for treating this blood cancer.

We are the Synchemia Research Chemical specializes in manufacturing and supplying of Bendamustine impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related Bendamustine works by interfering with the growth and spread of cancer cells. It's usually administered intravenously, and its side effects can include nausea, fatigue, and a risk of infection due to its effects on bone marrow. Always consult a healthcare professional for specific medical advice or treatment options. Buy Reliable and High-Purity Bendamustine Impurities, Delivered by Synchemia Research Chemicals.

Pharmaceutical Reference Standards

Bendamustine Hydrochloride

CAT No : SRC-B1411

CAS No: 3543-75-7

Mol.F.: C16H202N3O2 : HCl

Mol.Wt.: 358.3 : 36.5 g/mol

Inv. Status: Custom Synthesis

Bendamustine Deschloroethyl Acid Ethyl Ester

CAT No : SRC-B1412

CAS No: 2517968-40-8

Mol.F.: C16H22ClN3O2

Mol.Wt.: 323.8 g/mol

Inv. Status: In Stock

Bendamustine USP Related Compound D

CAT No : SRC-B1413

CAS No: 1797881-48-1

Mol.F.: C14H18ClN3O2 : HCl

Mol.Wt.: 295.8 : 36.5 g/mol

Inv. Status: Custom Synthesis

Bendamustine Dideschloroethyl Acid Impurity

CAT No : SRC-B1414

CAS No: 914626-62-3

Mol.F.: C12H15N3O2

Mol.Wt.: 233.3 g/mol

Inv. Status: Custom Synthesis

Bendamustine USP Related Compound C

CAT No : SRC-B1415

CAS No: 3543-74-6

Mol.F.: C18H27N3O4

Mol.Wt.: 349.4 g/mol

Inv. Status: Custom Synthesis

Bendamustine USP Related Compound A

CAT No : SRC-B1416

CAS No: 109882-30-6

Mol.F.: C16H23N3O4

Mol.Wt.: 321.4 g/mol

Inv. Status: Custom Synthesis

Bendamustine USP Related Compound I (HCl)

CAT No : SRC-B1417

CAS No: NA

Mol.F.: C18H25Cl2N3O2 : HCl

Mol.Wt.: 386.3 : 36.5 g/mol

Inv. Status: Custom Synthesis

Bendamustine Methyl Ester (HCl)

CAT No : SRC-B1418

CAS No: NA

Mol.F.: C17H23Cl2N3O2 : HCl

Mol.Wt.: 372.3 : 36.5 g/mol

Inv. Status: Custom Synthesis

Bendamustine Monohydroxy Acid Ethyl Ester

CAT No : SRC-B1419

CAS No: 898224-95-8

Mol.F.: C18H26ClN3O3

Mol.Wt.: 367.9 g/mol

Inv. Status: Custom Synthesis

Bendamustine USP Related Compound E (HCl)

CAT No : SRC-B1421

CAS No: 109882-26-0

Mol.F.: C16H22ClN3O3 : HCl

Mol.Wt.: 339.8 : 36.5 g/mol

Inv. Status: Custom Synthesis